Objective To evaluate the effectiveness and safety of medical sodium hyaluronate gels on the prevention of postoperative adhesion after abdominal and pelvic operation in the Department of general surgery, and discuss its clinical practical value. Methods Total 521 patients undergoing pelvic and abdominal operation were selected and randomly divided into experimental group(263cases)and control group(258cases).The sodium hyaluronate gels were used in the experimental group to coat over the operative area and adjacent parts, but not in the control group. After the surgery, the recorded data was analyzed statisticaly. Results In the experimental group: the mean time for passage of stools(19.8±1.7)h, the leucocyte count increased:8.0%(21cases),physical examination with the pain and discomfort:6.8%(18cases),post-operative adhesion:16cases included 3 cases of type Ⅰ and 13 cases of type Ⅱ.In the control group: the mean time for passage of stools(37.1±3.6)h, the leucocyte count increase:40.7%(105cases),physical examination with the pain and discomfort:24.0%(62cases),post-operative adhesion:94 cases include 39 cases of type Ⅰ and 55 cases of type Ⅱ.Conclusion The sodium hyaluronate gels may decrease the risk of postoperative adhesion formation, reduce the incidence of postoperative infection, pain, discomfort and other symptoms. It is worthy of clinical application and promotion.
Reference from Chinese Journal of General Practice
Writer: Gu Qiu-zhong, the First people's Hospital of Pinghu, Zhejiang, China.
-
singclean | 2017-08-14
Singclean’s Medical Sodium Hyaluronate Gel for Bone Joint Gained EU MDR CE Certification, Ranking Among First 3 Globally! 协合医疗骨科医用透明质酸钠凝胶成功斩获欧盟MDR CE认证!跻身全球前三!This achievement sets multiple industry records: it is the first MDR CE certificate for hyaluronic acid-based orthopedic products ever issued by DNV worldwide. Singclean Medical has become the first Chinese company to obtain such certification in this category and has successfully ranked among the first 3 companies globally to secure a viscosupplementation MDR CE certificate. This accomplishment underscores Singclean Medical's technological expertise and international competitiveness in the field of orthopedic biomaterials and hyaluronic acid applications. 此次认证创造了多项行业纪录:这是DNV在全球范围内签发的首张透明质酸骨科类MDR CE证书;协合医疗为中国首家获此证书的企业,更成功跻身全球前三。这一成绩,充分彰显了协合医疗在骨科生物医用材料及透明质酸领域的技术积累与国际竞争力。 -
singclean | 2017-08-14
Singclean Medical’s 2nd International Aesthetic Medicine Leadership Summit Concludes Successfully in Shanghai Shanghai, August 27, 2026 – The 2nd International Aesthetic Medicine Leadership Summit, hosted by Singclean Medical, was held at W Shanghai – The Bund, within the IMCAS China Congress venue. Under the theme “Global Vision, Opening a New Chapter,” the summit served as a cross‑border, multi‑disciplinary platform for professional exchange, gathering an impressive lineup of leading physicians and global partners. -
singclean | 2017-08-14
Singclean Medical to Showcase Innovative Aesthetic and Medical Solutions at Dubai Derma 2026 and Medical Fair Asia 2026HANGZHOU, China – Hangzhou Singclean Medical Products Co., Ltd., a leading innovator in absorbable biomaterials and medical aesthetic solutions, has announced its participation in two major international exhibitions in September 2026: Dubai Derma 2026 in the United Arab Emirates and Medical Fair Asia 2026 in Singapore.